Company / Free Cash Flow
ImageneBio, Inc. Free Cash Flow History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$80.2M
FY2024
5-year range
-$80.2M / -$38.6M
FY2021-FY2024
Trend
-6.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has declined for 3 consecutive years, from -$39M in FY2021 to -$80M in FY2024.
Based on SEC 10-K filings.
-$80M in FY2024.
Declined from -$62M to -$80M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- ImageneBio, Inc.'s free cash flow has declined for 3 consecutive years.
- In FY2024, free cash flow decreased 6.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -$80.2M | -6.1% |
| FY2023 | -$75.5M | -21.8% |
| FY2022 | -$62.0M | -60.7% |
| FY2021 | -$38.6M | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026